Sign In
Buy VANI
$1.28
-0.0200 (-1.54%)
At Close: Jun 03, 2026
Second Sight Medical stock tumbles after private placement of stock at 46% discount
08:35am, Wednesday, 24'th Mar 2021
Shares of Second Sight Medical Products Inc. tumbled 25% to pace all premarket decliners on Wednesday, after the implantable visual prosthetics company announced a large private placement of common st
EYES Stock Price Falls Over 20% Pre-Market: Why It Happened
08:13am, Wednesday, 24'th Mar 2021
The stock price of Second Sight Medical Products Inc (NASDAQ: EYES) fell by over 20% pre-market. This is why it happened.
Second Sight Medical Products Announces $27.9 Million Private Placement of Common Stock
07:00am, Wednesday, 24'th Mar 2021
LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES), (the "Company" or "Second Sight"), a leading developer and marketer of implantable visual prosthetics that are intende
Second Sight Medical Products Is No Short Squeeze
05:16am, Tuesday, 23'rd Mar 2021
EYES stock jumped higher off a very encouraging FDA approval but now is the time to apply a little more scrutiny to the Second Sight Medical investment. The post Second Sight Medical Products Is No Sh
FDA Approval Sheds New Light on Second Sight Medical Products
04:24pm, Monday, 22'nd Mar 2021
You won't believe your eyes when you see the ultra-bullish price action in EYES stock, along with the game-changing regulatory announcement. The post FDA Approval Sheds New Light on Second Sight Medic
EYES Stock Price Increased 486.07% Over The Past Month: Why It Happened
10:11pm, Wednesday, 17'th Mar 2021
The stock price of Second Sight Medical Products Inc (NASDAQ: EYES) increased by 486.07% over the past month. This is why it happened.
EYES Stock Price Increases 35.71%: Why It Happened
06:00am, Saturday, 13'th Mar 2021
The stock price of Second Sight Medical Products Inc (NASDAQ: EYES) increased by 35.71% yesterday. This is why it happened.
EYES Stock Price Increases Over 30% Pre-Market: Why It Happened
05:03am, Tuesday, 09'th Mar 2021
The stock price of Second Sight Medical Products Inc (NASDAQ: EYES) is trading at over 30% pre-market. This is why it happened.
Continuation of the business combination project between Pixium Vision et Second Sight Medical Products
03:00am, Tuesday, 09'th Mar 2021
Paris, France, March 09, 2021 – Pixium Vision (Euronext Growth Paris - FR0011950641) announces that the business combination with Second Sight Medical Products, Inc. (« Second Sight ») (Nasdaq:
Why Second Sight Medical Products Has Skyrocketed 723% In 2 Trading Sessions
10:39pm, Monday, 08'th Mar 2021
Second Sight Medical Products Inc (NASDAQ: EYES) shares have soared above 723% over the previous two trading sessions with the stock touching an intraday high of $14.83 on Monday. The shares register
Second Sight Medical stock skyrockets 8-fold in 2 days after FDA approves retinal prosthesis system
12:16pm, Monday, 08'th Mar 2021
Shares of Second Sight Medical Products Inc. soared 104.2% on heavy volume in midday trading Monday, bringing its two-day gain to 728.7%, after the Food and Drug Administration approved the company's
EYES Stock: 12 Things for Second Sight Medical Investors to Know as Shares Keep Rocketing
10:46am, Monday, 08'th Mar 2021
Second Sight Medical Products (EYES) stock just can't stop soaring higher following approval from the FDA on Friday for one of its devices. The post EYES Stock: 12 Things for Second Sight Medical Inve
EYES Stock Price Increases Over 55% Pre-Market: Why It Happened
09:14am, Monday, 08'th Mar 2021
The stock price of Second Sight Medical Products Inc (NASDAQ: EYES) is trading at over 55% pre-market. This is why it happened.
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
04:50pm, Friday, 05'th Mar 2021
So what did the stock market do today? We watched a major turnaround in the stock market and saw a few winners and losers emerge.
EYES Stock: The Big FDA News That Has Second Sight Shares Soaring
11:45am, Friday, 05'th Mar 2021
Second Sight (EYES) stock is soaring higher Friday after announcing approval from the FDA for its Argus 2s Retinal Prosthesis System. The post EYES Stock: The Big FDA News That Has Second Sight Shares
